Proprietary small-molecule formulation extends beyond conventional ROCK inhibitors to accelerate recovery and improve reproducibility in stem cell and organoid research. MONMOUTH JUNCTION, N.J. -- TheWell Bioscience, a leader in xeno-free 3D cell culture technologies, today announced the launch of RocketCell™ Cell Viability Enhancer (1000X), a next-generation cell recovery reagent engineered to maximize cell survival, metabolic [...]

Shimadzu Corporation completed the acquisition on July 10 of all shares of Glass HoldCo s.r.o., which indirectly holds all shares of TESCAN GROUP, a.s. (“TESCAN”), a Europe-based pioneer in electron microscopy, thereby making TESCAN a wholly owned subsidiary. This transaction completes the share acquisition procedures for Glass HoldCo s.r.o. that Shimadzu announced on December 25, [...]

PLEASANTON, CA -- Measuring TNF-α accurately sounds straightforward until researchers begin comparing data across experiments. Serum and plasma matrices can affect cytokine recovery. Low-abundance samples may approach assay detection limits. Standard curves can shift when protocols, operators, or reagent lots change. For laboratories studying inflammatory signaling, immune activation, or therapeutic response, this variability is more [...]

Dolsten Takes BenchSci's First-Ever Chairman Role as EMET Scales Across Global Biopharma TORONTO — BenchSci, a leading provider of AI software for biopharma research and development, today announced the appointment of Dr. Mikael Dolsten, M.D., Ph.D., as Chairman of its Board of Directors, effective June 2026 — the first Chairman role in the company's history. [...]

SAN JOSE, Calif. — Takara Bio USA, Inc., a wholly owned subsidiary of Takara Bio Inc. ("Takara Bio"), today announced that Carol Lou will retire as President and Chief Executive Officer of Takara Bio USA on July 10 after more than two decades with the company. Andrew Farmer, D.Phil., who has served as Chief Scientific [...]

Amsterdam, NL / Oakland, CA, USA — AkzoNobel, a global leader in paints and coatings, and Albert Invent, who is building the future of chemistry R&D, today announced an AI transformation partnership with AkzoNobel’s global R&D organization. AkzoNobel’s Digital Workbench initiative is designed to connect laboratory workflows, structure scientific data, and put modern AI tools [...]

Dolsten Takes BenchSci's First-Ever Chairman Role as EMET Scales Across Global Biopharma TORONTO -- BenchSci, a leading provider of AI software for biopharma research and development, today announced the appointment of Dr. Mikael Dolsten, M.D., Ph.D., as Chairman of its Board of Directors, effective June 2026 — the first Chairman role in the company's history. [...]

Uppsala, Sweden – Navinci Diagnostics AB (”Navinci”) today announces that the Company has initiated a pilot project together with Lumito AB (publ) (“Lumito”) to evaluate the possibilities of combining the companies’ respective technologies within advanced tissue analysis. The pilot project aims to combine Lumito’s high-sensitivity image analysis platform with Navinci’s in situ Proximity Ligation Technology (isPLA). By [...]

Agreement with leading life sciences company Illumina strengthens Bifrost's path to commercial deployment of next-generation optical pooled screening technology. BERKELEY, Calif. -- Bifrost Biosystems today announced that it has secured a commercial supply agreement with Illumina enabling integration of Illumina's industry-standard sequencing-by-synthesis (SBS) chemistry into its optical pooled screening (OPS) platform slated to be commercially available in early [...]

Uppsala, Sweden — Navinci Diagnostics AB (”Navinci”) today announces that the Company has initiated a pilot project together with Lumito AB (publ) (“Lumito”) to evaluate the possibilities of combining the companies’ respective technologies within advanced tissue analysis. The pilot project aims to combine Lumito’s high-sensitivity image analysis platform with Navinci’s in situ Proximity Ligation Technology (isPLA). By [...]